Open AccessJournal Article
Modulation of Radiation Response after Epidermal Growth Factor Receptor Blockade in Squamous Cell Carcinomas: Inhibition of Damage Repair, Cell Cycle Kinetics, and Tumor Angiogenesis
Shyhmin Huang,Paul M. Harari +1 more
Reads0
Chats0
TLDR
The collective data suggest that the profound in vivo antitumor activity identified in the xenograft setting when C225 is combined with radiation derives from more than simply the antiproliferative and cell cycle effects of EGFR system inhibition.Abstract:
We
have recently demonstrated that molecular blockade of the epidermal
growth factor receptor with the anti-epidermal growth factor receptor
(EGFR) monoclonal antibody C225 enhances the in vitro
radiosensitivity of human squamous cell carcinomas (SCCs) derived from
the head and neck. In the present study, we further investigated the
capacity of C225 to modulate the in vitro and in
vivo radiation response of human SCC tumor cells and
xenografts, and we examined several potential mechanisms that may
contribute to the enhanced radiation response induced by C225. Tumor
xenograft studies demonstrated complete regression of both newly
established (20 mm 3 ) and well-established (100
mm 3 ) SCC tumors over a 55–100 day follow-up period in
athymic mice treated with the combination of C225 (i.p. injection) and
radiation. Cell cycle analysis via flow cytometry confirmed that
combined treatment with C225 and radiation induced an accumulation of
cells in the more radiosensitive cell cycle phases (G 1 ,
G 2 -M) with concurrent reduction in the proportion of cells
in the more radioresistant S phase. Results from sublethal damage
repair and potentially lethal damage repair analyses in cultured SCC
cells demonstrated a strong inhibitory effect of C225 on postradiation
damage repair. Further, exposure of SCC cells to C225 induced a
redistribution of DNA-dependent protein kinase from the nucleus to the
cytosol, suggesting one potential mechanism whereby C225 may influence
the cellular response to radiation. Immunohistochemical analysis of SCC
tumor xenografts after systemic administration of C225 demonstrated
inhibition of the in vivo expression of tumor
angiogenesis markers, including vascular endothelial growth factor and
Factor VIII. Taken together, the collective data suggest that the
profound in vivo antitumor activity identified in the
xenograft setting when C225 is combined with radiation derives from
more than simply the antiproliferative and cell cycle effects of EGFR
system inhibition. In addition to antiproliferative growth inhibition,
EGFR blockade with C225 appears to influence the capacity of human SCCs
to effect DNA repair after exposure to radiation, and to express
classic markers of tumor angiogenesis.read more
Citations
More filters
Journal Article
Antitumour Activity of S-1 in Combination with Cetuximab on Human Gastric Cancer Cell Lines In Vivo
TL;DR: It is suggested that cetuximab-mediated down-regulation of TYMS enhances the antitumour effect of S-1 and provide a rationale for designing novel combination chemotherapy regimens for patients with advanced gastric cancer.
Journal ArticleDOI
Radiosensitization and Modulation of p44/42 Mitogen-Activated Protein Kinase by 2-Methoxyestradiol in Prostate Cancer Models
TL;DR: Data show that 2ME2 is an effective radiosensitizing agent against human prostate cancer xenografts, and that the mechanism may involve a decrease in mitogen-activated protein kinase phosphorylation by 2 ME2.
Journal ArticleDOI
EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790 M resistant mutation in lung cancer cells.
Xiang Cao,Yi Zhou,Hongfang Sun,Miao Xu,Xiaowen Bi,Zhihui Zhao,Binghui Shen,Fengyi Wan,Zhuan Hong,Lei Lan,Lan Luo,Zhigang Guo,Zhimin Yin +12 more
TL;DR: It is shown that treatment with low-dose EGFR-TKI results in the emergence of the EGFR T790 M mutation and in the reduction of HSP70 protein levels in HCC827 cells, and that HSP 70 interacts with multiple enzymes in the base excision repair pathway and promotes not only the efficiency but also the fidelity of BER.
Journal ArticleDOI
The Enhancement of Radiosensitivity in Human Esophageal Carcinoma Cells by Thalidomide and Its Potential Mechanism
TL;DR: Thalidomide was able to enhance the radiosensitivity of TE1 cells in vitro, which could be closely related to its suppressive effects on the expression of VEGF inTE1 cells, but had no obvious effects onThe cell cycle.
Journal ArticleDOI
Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: Results of in vitro and in vivo studies
Itay Barnea,Sasha Haif,Rom Keshet,Vicky Karaush,Shahar Lev-Ari,Avi Khafif,Alexander Shtabsky,Yosef Yarden,Akiva Vexler,Rami Ben Yosef +9 more
TL;DR: The role of ErbB‐4 in cancer cell biology and the effect of anti‐ErbBB‐1 and anti-Erb B‐4 monoclonal antibodies were evaluated in this study.
References
More filters
Journal ArticleDOI
Principles and practice of radiation oncology
Carlos A. Perez,Luther W. Brady +1 more
TL;DR: The principles and practice of radiation oncology are studied in detail in a systematic manner in the context of cancer diagnosis and treatment.
Journal Article
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Alicia M. Viloria Petit,Janusz Rak,Mien Chie Hung,Patricia Rockwell,Neil I. Goldstein,Brian M. Fendly,Robert S. Kerbel +6 more
TL;DR: Therapeutic disruption of EGFR or ErbB2/neu protein function in vivo may result in partial suppression of angiogenesis, a feature that could enhance the therapeutic index of such agents in vivo and endow them with anti-tumor effects, the magnitude of which may be out of proportion with their observed cytostatic effects in monolayer tissue culture.
Journal Article
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.
TL;DR: Examination of C225 effects on radiation response in SCCs demonstrates enhancement in radiosensitivity and amplification of radiation-induced apoptosis, and C225 represents a promising growth-inhibitory agent that can influence cellular proliferation, apoptosis and radiosensitivity in S CCs of the head and neck.
Journal ArticleDOI
Combined effects of angiostatin and ionizing radiation in antitumour therapy
Helena J. Mauceri,Nader Hanna,Michael A. Beckett,David H. Gorski,M J Staba,Kerri Anne Stellato,Kevin Bigelow,Ruth Heimann,Stephen T. Gately,Mohanraj Dhanabal,Gerald A. Soff,Vikas P. Sukhatme,Donald Kufe,Ralph R. Weichselbaum +13 more
TL;DR: The results show an antitumour interaction between ionizing radiation and angiostatin for four distinct tumour types, at doses of radiation that are used in radiotherapy.
Journal Article
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Paul Perrotte,Takashi Matsumoto,Keiji Inoue,Hiroki Kuniyasu,Beryl Y. Eve,Daniel J. Hicklin,Robert Radinsky,Colin P.N. Dinney +7 more
TL;DR: Therapy with anti-EGFR MAb C225 has a significant antitumor effect mediated, in part, by inhibition of angiogenesis, and down-regulation of these angiogenic factors preceded the involution of blood vessels.